As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
We are very excited to launch our new website! Please take a few moments to click around and explore...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...